Abstract
Background People with schizophrenia on average are more socially isolated, lonelier, have more social cognitive impairment, and are less socially motivated than healthy individuals. People with bipolar disorder also have social isolation, though typically less than that seen in schizophrenia. We aimed to disentangle whether the social cognitive and social motivation impairments observed in schizophrenia are a specific feature of the clinical condition v. social isolation generally. Methods We compared four groups (clinically stable patients with schizophrenia or bipolar disorder, individuals drawn from the community with self-described social isolation, and a socially connected community control group) on loneliness, social cognition, and approach and avoidance social motivation. Results Individuals with schizophrenia (n = 72) showed intermediate levels of social isolation, loneliness, and social approach motivation between the isolated (n = 96) and connected control (n = 55) groups. However, they showed significant deficits in social cognition compared to both community groups. Individuals with bipolar disorder (n = 48) were intermediate between isolated and control groups for loneliness and social approach. They did not show deficits on social cognition tasks. Both clinical groups had higher social avoidance than both community groups Conclusions The results suggest that social cognitive deficits in schizophrenia, and high social avoidance motivation in both schizophrenia and bipolar disorder, are distinct features of the clinical conditions and not byproducts of social isolation. In contrast, differences between clinical and control groups on levels of loneliness and social approach motivation were congruent with the groups' degree of social isolation.
Original language | English |
---|---|
Pages (from-to) | 2015-2023 |
Number of pages | 9 |
Journal | Psychological Medicine |
Volume | 54 |
Issue number | 9 |
Early online date | 5 Feb 2024 |
DOIs | |
State | Published - 1 Jul 2024 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© The Author(s), 2024.
Funding
Dr Green has been a consultant or speaker for Biogen, Otsuka, Sumitomo Pharma and Teva. Dr Horan is an employee of and holds equity in Karuna Therapeutics. Dr McCleery has received research funding from Alkermes PLC, and payment for assessment services from MedAvante-Prophase. Dr Miklowitz has received research funding from the Danny Alberts Foundation, the Attias Family Foundation, the Carl and Roberta Deutsch Foundation, the Kayne Family Foundation, and AIM for Mental Health; and book royalties from Guilford Press and John Wiley and Sons. The other authors do not have any conflict of interest. Support for this study came from NIMH grant R01 MH110470 to M.F. Green.
Funders | Funder number |
---|---|
AIM for Mental Health | |
Danny Alberts Foundation | |
Guilford Press and John Wiley and Sons | |
National Institute of Mental Health | R01 MH110470 |
Alkermes | |
Attias Family Foundation | |
Carl and Roberta Deutsch Foundation | |
Kayne Family Foundation |
Keywords
- bipolar disorder
- schizophrenia
- social cognition
- social isolation
- social motivation